Govt to consider ban on codeine-based cough syrups
After recent worries about their abuse as drugs and intoxicants were raised by MPs, the government is poised to outlaw popular codeine-based cough syrups and formulations.
Andhra unit of Aurobindo Pharma receives Form 483 with three USFDA observations
Form 483 is sent to a firm’s management following an inspection when the investigator observes any conditions that, in its opinion, may constitute breaches of the Food, Drug, and Cosmetic (FD&C) Act and related Acts.
Directors of pharma firm named in a fraud case
In connection with a 1 crore bank fraud case that the CBI was looking into, a local court has found directors of a pharmaceutical business with offices in Chennai guilty.
SII informs Center it can deliver 1 crore doses of qHPV vaccine to prevent cervical cancer
By December 2022, Serum Institute of India would be able to provide 1 crore doses of its locally manufactured quadrivalent human papillomavirus vaccine (qHPV) against cervical cancer.
NPPA extends deadline for five medical devices' trading margin capping
The deadline for the trade margin capping of the five medical devices that are necessary during the Covid-19 pandemic period has been extended by the National Pharmaceutical Pricing Authority (NPPA) until December 31, 2022.
Oral testosterone replacement therapy Kyzatrex received FDA approval
Food and Drug Administration has approved KyzatrexTM (testosterone undecanoate) for the treatment of diseases linked to a lack of endogenous testosterone in adult males.
Genentech announced phase III IMscin001 study met co-primary goals
The phase III IMscin001 study examining
a subcutaneous formulation of Tecentriq
(atezolizumab) was completed with the
achievement of the co-primary endpoints,
as per an announcement from Genentech,
a member of the Roche Group.
